4WX-20116-26061
3 vaccinations
4 coded responses
36 check-ins
4 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 483 / MI
- Registered
- 2020-12-21
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-21
Registered in v-safe
-
2020-12-21
Dose 1 — Pfizer-BioNTech
- 2020-12-21
-
2020-12-22
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2020-12-23
- 2020-12-24
- 2020-12-25
- 2020-12-26
- 2020-12-27
- 2020-12-28
- 2021-01-04
- 2021-01-11
-
2021-01-12
Dose 2 — Pfizer-BioNTech
-
2021-01-12
Health check-in — day 0, dose 2Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-01-13
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-13
Report sent to call center — days 1–6 daily, dose 2Be unable to do your normal daily activities1 call case(s)
- 2021-01-14
- 2021-01-15
- 2021-01-16
- 2021-01-17
- 2021-01-18
- 2021-01-20
- 2021-01-26
- 2021-02-02
- 2021-02-09
- 2021-02-18
- 2021-02-23
- 2021-04-13
- 2021-07-15
-
2021-09-24
Dose 3 — Pfizer-BioNTech
- 2021-09-29
-
2021-09-30
Survey response — days 1–6 daily, dose 3MedDRA: Menstruation irregular — Feeling: GoodFree text: Lack of periodMedDRA releases: 2024-11 · check-in free text available
-
2021-10-01
Survey response — day 7, dose 3MedDRA: Menstruation delayed — Feeling: GoodFree text: Missed periodMedDRA releases: 2024-11 · check-in free text available
- 2021-10-08
- 2021-10-15
- 2021-10-24
-
2021-10-29
Survey response — day 35, dose 3MedDRA: Pregnancy — Feeling: GoodFree text: PregnancyMedDRA releases: 2024-11 · check-in free text available
- 2021-11-05
- 2021-12-26
-
2022-03-25
Survey response — 6 months, dose 3MedDRA: Stillbirth — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · HospitalizationFree text: StillbirthMedDRA releases: 2024-11 · check-in free text available
-
2022-03-25
Report sent to call center — 6 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prHospitalization · 1 call case(s)
- 2022-03-28
- 2022-09-26
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-21 | Pfizer-BioNTech | |
| 2 | 2021-01-12 | Pfizer-BioNTech | |
| 3 | 2021-09-24 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-01-13 | priority 2/3 | |
| 2022-03-25 | Unsuccessful |
Free text
Release 9 — days 1–6 daily, dose 3
Systemic reaction (other): Lack of period
Release 9 — day 7, dose 3
Systemic reaction (other): Missed period
Release 10 — day 35, dose 3
Symptoms: Pregnancy
Release 11 — 6 months, dose 3
Symptoms: Stillbirth
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Pregnancy | · | · | ✓ |
| SD | Stillbirth | · | · | ✓ |
| SRO | Menstruation delayed | · | · | ✓ |
| SRO | Menstruation irregular | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release